| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/12/1999 | US5858017 Urologic irrigation solution and method for inhibition of pain, inflammation and spasm |
| 01/12/1999 | CA2151890C Quinoline carboxylic acid derivatives having 7-(4-aminomethyl-3-oxime)pyrrolidine substituent and processes for preparing thereof |
| 01/12/1999 | CA2138122C Pharmaceutical preparations for inhibiting tumours associated with prostate adenocarcinoma, stomach and breast cancer |
| 01/12/1999 | CA2117903C Targeted cleavage of rna using eukaryotic ribonuclease and external guide sequence |
| 01/12/1999 | CA2103825C 17-hydroxyiminomethyl-5.beta., 14.beta.-androstane derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same |
| 01/12/1999 | CA2065809C Gastroresistant pharmaceutical formulations for oral administration containing salts of bile acids |
| 01/12/1999 | CA2065652C Controlled release gastroresistant pharmaceutical formulations for oral administration containing bile acids and their salts |
| 01/12/1999 | CA1340316C 8-alkoxyquinolonecarboxylic acid salts thereof excellent in the selecti ve toxicity and process of preparing the same |
| 01/10/1999 | CA2236493A1 Mura |
| 01/08/1999 | CA2236473A1 Novel pcra |
| 01/08/1999 | CA2236468A1 Novel use |
| 01/07/1999 | WO1999000654A2 Radiolabeled farnesyl-protein transferase inhibitors |
| 01/07/1999 | WO1999000510A1 Regulation of transcription in mammalian cells and viral replication by a tetracyclin repressor |
| 01/07/1999 | WO1999000507A1 Phosphatidylinositol 4,5-bisphosphate 5-phosphatase from human |
| 01/07/1999 | WO1999000498A1 Human nk-3 related prostate specific gene-1 |
| 01/07/1999 | WO1999000436A2 Polymerisates of unsaturated saccharide acids and their derivatives, copolymerisates thereof with ethylenically unsaturated compounds and method for preparing the same |
| 01/07/1999 | WO1999000401A1 3'-monophosphorylating oligonucleotides |
| 01/07/1999 | WO1999000399A1 Method of producing tiazofurin and other c-nucleosides |
| 01/07/1999 | WO1999000393A1 Quinolone carboxylic acid derivatives |
| 01/07/1999 | WO1999000391A1 Tricyclic pyrazolo-pyridazinone analogues as gaba-a receptor ligands |
| 01/07/1999 | WO1999000389A1 5-[(HETEROARYL)ALKYL]-3-OXO-PYRIDO[1,2-a]BENZIMIDAZOLE-4-CARBOXAMIDE DERIVATIVES USEFUL IN TREATING CENTRAL NERVOUS SYSTEM DISORDERS |
| 01/07/1999 | WO1999000387A1 Novel n-benzenesulphonyl-l-proline compounds, preparation method and use in therapy |
| 01/07/1999 | WO1999000385A1 3-pyridyl-1-aza-bicyclo-alkane derivatives for prevention and treatment of cns disorders |
| 01/07/1999 | WO1999000384A1 New quinoxaline dione derivatives, the production thereof and use of the same in medicaments |
| 01/07/1999 | WO1999000383A1 Eprosartan monohydrate |
| 01/07/1999 | WO1999000381A1 Bis-indole derivatives having antimetastatic activity, a process for their preparation and pharmaceutical compositions containing them |
| 01/07/1999 | WO1999000380A1 Omeprazole sodium salt |
| 01/07/1999 | WO1999000379A1 4-[(1h-imidazol-4-yl)piperidin-1-yl]anilide derivatives, their preparation and application in therapy |
| 01/07/1999 | WO1999000373A1 Benzimidazole derivatives |
| 01/07/1999 | WO1999000372A1 Sulfonamide compounds and medicinal use thereof |
| 01/07/1999 | WO1999000371A1 Phenylalkyl derivatives with thrombin-inhibiting effect |
| 01/07/1999 | WO1999000369A1 Process for preparing nifedipine |
| 01/07/1999 | WO1999000368A1 Substituted 3-(benzylamino)piperidine derivatives and their use as therapeutic agents |
| 01/07/1999 | WO1999000361A1 Ace-inhibitor nitric salts |
| 01/07/1999 | WO1999000356A1 Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides |
| 01/07/1999 | WO1999000353A1 Novel thyroid receptor ligands and method |
| 01/07/1999 | WO1999000346A1 Synthesis of dihydrohonokiol compositions |
| 01/07/1999 | WO1999000135A1 Composition comprising vitamin k and vitamin d, for treating or preventing osteoporosis |
| 01/07/1999 | WO1999000134A1 New combination of antiasthma medicaments |
| 01/07/1999 | WO1999000133A1 Method for optimizing retinal and optic nerve health |
| 01/07/1999 | WO1999000132A1 Use of phospholamban inhibitors for increasing coronary flow |
| 01/07/1999 | WO1999000131A1 Novel process for manufacturing paroxetine solid dispersions |
| 01/07/1999 | WO1999000130A1 Method for treating vulvar vestibulitis |
| 01/07/1999 | WO1999000129A1 Calcium blockers to treat proliferative vitreoretinopathy |
| 01/07/1999 | WO1999000128A1 Antithrombotic agents |
| 01/07/1999 | WO1999000127A1 Antithrombotic agents |
| 01/07/1999 | WO1999000126A1 Antithrombotic agents |
| 01/07/1999 | WO1999000123A1 Use of a drug capable of modulating the regulation of upc-2 and method for screening for potential drugs against obesity |
| 01/07/1999 | WO1999000122A1 Method for reducing body weight |
| 01/07/1999 | WO1999000121A1 Antithrombotic agents |
| 01/07/1999 | WO1999000119A1 Use of a specific antagonist of 5ht2 receptors for preparing medicines useful for treating sleep-disordered breathing |
| 01/07/1999 | WO1999000118A1 Use of azulene derivatives as metalloprotein inhibitors |
| 01/07/1999 | WO1999000117A2 Neuroprotective methods and reagents |
| 01/07/1999 | WO1999000116A2 Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them |
| 01/07/1999 | WO1999000115A1 Use of antagonists or partial agonists of the vanilloid receptor complexes for treating neurodegenerative diseases |
| 01/07/1999 | WO1999000114A2 Biologically active 1,3-bis-aromatic-prop-2-en-1-ones, 1,3-bis-aromatic-propan-1-ones, and 1,3-bis-aromatic-prop-2-yn-1-ones |
| 01/07/1999 | WO1999000113A1 Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof |
| 01/07/1999 | WO1999000111A1 Proliposome powders for inhalation stabilised by tocopherol |
| 01/07/1999 | WO1999000109A1 Composition comprising a lipoaminoacid and a tannin-rich plant extract |
| 01/07/1999 | WO1999000106A1 Intra-oral antioxidant preparations |
| 01/07/1999 | WO1999000079A1 Skin aging and wound treatment using cell migration agents |
| 01/07/1999 | WO1999000019A1 Methods of treating the symptoms of atrophic vaginitis and altered sexual behavior in postmenopausal women |
| 01/07/1999 | WO1999000018A1 Methods of treating symptoms of impaired memory, concentration and cognition in postmenopausal women |
| 01/07/1999 | WO1999000015A1 Method of enhancing magnesium absorption and prevention of atherosclerosis |
| 01/07/1999 | WO1998046588A3 Compounds and therapies for the prevention of vascular and non-vascular pathologies |
| 01/07/1999 | WO1998045427A3 Insulin-like growth factor agonist peptides |
| 01/07/1999 | WO1998044893A3 Method and formulation for treating vascular disease |
| 01/07/1999 | WO1998044808A3 PROCESS FOR ENHANCING IMMUNE RESPONSE IN ANIMALS USING β-CAROTENE AS A DIETARY SUPPLEMENT |
| 01/07/1999 | WO1998042321A3 Liquid compositions comprising lamivudine |
| 01/07/1999 | WO1998037872A3 Transdermal drug delivery system for the administration of tamsulosin, and related compositions and methods of use |
| 01/07/1999 | WO1998035048A3 Engineered protein kinases which can utilize modified nucleotide triphosphate substrates |
| 01/07/1999 | EP0889136A1 Exocellular polysaccharide produced by streptococcus thermophilus |
| 01/07/1999 | EP0889135A1 Exocellular polysaccharide produced by streptococcus thermophilus |
| 01/07/1999 | EP0889132A2 Streptococcus pneumoniae gidA2 polynucleotides and polypeptides |
| 01/07/1999 | EP0889131A2 Staphylococcus aureus gidA2 polynucleotides and polypeptides |
| 01/07/1999 | EP0889130A2 GidB polypeptides from Streptococcus pneumoniae |
| 01/07/1999 | EP0889129A2 GidA1 polypeptides from Staphylococcus aureus |
| 01/07/1999 | EP0889128A2 midA1 polypeptides from Streptococcus pneumoniae |
| 01/07/1999 | EP0889127A1 Serine/threonine protein kinase (H-SGK2) |
| 01/07/1999 | EP0889126A2 YNL075W/HTXFT19 polypeptide |
| 01/07/1999 | EP0889123A2 MurC gene of Staphylococcus aureus coding for UDP-N-acetylmuramate:L-alanine Ligase |
| 01/07/1999 | EP0889122A2 Inhibition of DNA Methyltransferase |
| 01/07/1999 | EP0889120A1 A micro-organism having reduced adaption to a particular environment |
| 01/07/1999 | EP0889055A1 Oligosulfated hyaluronic acid |
| 01/07/1999 | EP0889051A1 Triterpene derivatives and remedies for liver diseases |
| 01/07/1999 | EP0889044A1 5-(heteroaryl)alkyl)-3-oxo-pyrido(1,2-a)benzimidazole-4-carboxamide (PBI) derivatives useful in treating central nervous system disorders |
| 01/07/1999 | EP0889036A1 HIV protease inhibitors |
| 01/07/1999 | EP0889031A1 Simple process for producing high-quality captopril |
| 01/07/1999 | EP0888784A1 Cellulose ester wound dressing |
| 01/07/1999 | EP0888778A1 Colon selective drug delivery system and compositions comprising said system |
| 01/07/1999 | EP0888776A1 A product of heat treatment of uronic acid, food, drink or drug including the product |
| 01/07/1999 | EP0888775A2 Control of selective estrogen receptor modulators |
| 01/07/1999 | EP0888774A2 Soft gel Coenzyme Q10 formulation |
| 01/07/1999 | EP0888773A1 Use of petroselinic acid for the treatment of inflammations of superficial tissues |
| 01/07/1999 | EP0888772A1 Sustained-release metal valproate tablets |
| 01/07/1999 | EP0888771A1 Composition with topical anaesthetic activity |
| 01/07/1999 | EP0888541A1 Cryptic peptides and method for their identification |
| 01/07/1999 | EP0888457A1 Adeno-associated virus vector for boosting immunogenicity of cells |
| 01/07/1999 | EP0888453A1 Clostridium perfringens vaccines |
| 01/07/1999 | EP0888452A2 Extracellular matrix signalling molecules |